Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community
SITE POLL ARCHIVE

Important Notice: Opine Online provides an informal way for the research community to express its views on current topics. The results are not a scientific poll and do not necessarily reflect the percentages of all Alzheimer researchers who agree with these positions.

November 2004
Poll Question: To cure AD, do we need to understand APP and Abeta function?

Yes
77
No
22
We don't know enough to answer this question
20
Other (post comment to explain)
0
Responses: 119
Comments on Site Poll
  Comment by:  Vijendra Singh
Submitted 2 November 2004  |  Permalink Posted 3 November 2004

The APP and AP in AD is a good topic, but some important issues are not being investigated. I think the autoimmune response to AP is important but not investigated. Many years ago (as early as 1985), I advanced the "Autoimmune Hypothesis and Immunotherapy for AD," and even showed a significant increase of antibodies to AP-β in sera of AD patients (Singh, 1990 and Singh, 1997).

This finding has recently been replicated by others (Mruthini et al., 2004). Although these researchers did not even cite our work, I would like to emphasize the importance of this line of investigation for immunotherapy. We need to examine the potential of immune modulation therapy (IMT) and not just the antiinflammatory drugs as a treatment for AD patients.

View all comments by Vijendra Singh


  Comment by:  Victorio Rodriguez (Disclosure)
Submitted 24 November 2004  |  Permalink Posted 29 November 2004

To cure Alzheimer disease, we need to understand the basic mechanism of cell death, which has remained elusive until now.

Almost all the drugs used in clnical trials like sex hormones, NSAIDs, and androgens affect one or more carbonic anhydrase isozymes, but are not sufficient to treat the disease because these trials do not assay the level of carbonic anhydrase isozymes that are reduced during aging and disorders including Alzheimer disease and other neurodegenerative diseases.

Understanding APP and Aβ function could help, but not cure AD.

See U.S. Patent # 6821997 issued November 23,2004 which can be viewed at http://www.uspto.gov "Therapeutic and Prophylactic Treatment of Aging and Disorders of Aging in Humans" by Victorio C. Rodriguez M.D.

View all comments by Victorio Rodriguez


  Comment by:  Jacob Mack
Submitted 21 February 2005  |  Permalink Posted 21 February 2005

I agree with this comment. We could analyze APP and Aβ until we are blue in the face, but the point now is to take what we know about AD and propose new and ingenious treatment modalities.

Gene therapy certainly is not going to do it and neither is immunotherapy. NSAIDS show some preventive roles, but will not regress AD. Turn off every complement protein (c reactive protein signaler, etc.) and we still have AD, just not less progressive; try to destroy beta amyloid and you destroy neurons and activate glial cells. We have a very powerful positive feedback loop here. It is necessary to cut the chains that initiate and propagate neuronal degradation.

View all comments by Jacob Mack

Submit a Comment on this Site Poll
Cast your vote and/or make a comment on this poll. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad